Transcode Therapeutics, Inc. · NASDAQ:RNAZ

Unleash Immuno Oncolytics, Inc. reported a 9.94% stake in Transcode Therapeutics, Inc. (Schedule 13G)

Event Jul 23, 2026 · Filed Jul 28, 2026

Unleash Immuno Oncolytics, Inc. reported a 9.94% stake in Transcode Therapeutics, Inc., 300,000 shares, as a passive investor on Jul 23, 2026. Filed Jul 28, 2026 (Schedule 13G).

Stake
9.94%
Shares
300,000
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
Unleash Immuno Oncolytics, Inc.9.94%300,000

Source

View original at SEC

Related